FDA currently prohibits the use of NAC as a dietary supplement, and is concerned about a proposal for HHS to review certain regulations or let them expire.
Novel dietary ingredients often eschew a required approval process, and execs say this breeds adulteration, low-quality knockoffs, and possible health risks.
This webinar on 9/16 will explore the top 10 CFR 21 cGMP reasons why dietary supplement brand owners, manufacturers and distributers are issued warning letters.
The trade group requested particularly that FDA begin issuing import alerts for supplements and expand participation in the group’s quality assurance program.
During a webinar hosted by Natural Products Association, officials from Virginia and Louisiana questioned reports that progress was being made on the federal regulatory level.
FDA can and should use its authority and discretion under the Food, Drug & Cosmetic Act to allow CBD to be marketed with necessary regulations and restrictions, CRN said.
Purveyors of dietary supplements, IV 'therapies,' and ozone 'therapies' were accused by the FTC of purporting that their products could fight COVID-19.
The mushroom-based ingredient can make licensed support claims on immune function, bone health, and general well-being in both adults and children in the Canadian marketplace.
Dietary supplement industry urges continued aggressive prosecution against products promoted with illegal claims about prevention or treatment of COVID-19.
Due to COVID-19, FDA announced that it will begin conducting its inspection activities electronically for the remainder of the public health emergency.
Sales of cannabidiol-based products have soared during the past year, and now formulators are rolling out CBD products designed to ease a variety of ailments.
A flood of all types of consumer products in the marketplace warrants a review of available scientific evidence.
By Marilyn Barrett, PhD, Pharmacognosy Consulting, Inc., Mary Ellen Cosenza, PhD, MEC Regulatory & Toxicology Consulting, Steven Dentali, PhD, Dentali Botanical Sciences, and Sandy Bigelow, PhD, Vanguard Global Associates LLC04.02.20